Search Results - "Lampugnani, Maria G."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
  2. 2

    Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial by Lanfranconi, Silvia, Scola, Elisa, Meessen, Jennifer M T A, Pallini, Roberto, Bertani, Giulio A, Al-Shahi Salman, Rustam, Dejana, Elisabetta, Latini, Roberto

    Published in Lancet neurology (01-01-2023)
    “…Observations in people with cerebral cavernous malformations, and in preclinical models of this disorder, suggest that the β-blocker propranolol might reduce…”
    Get full text
    Journal Article
  3. 3